Antivirals for the treatment of mild and moderate COVID-19 in South Africa
While the majority of COVID‐19 cases in South Africa (SA) are mild, patients with severe COVID‐19 requiring hospitalisation present with significant morbidity and mortality and place a substantial burden on healthcare services. Given the low vaccine uptake in SA and other low‐ and middle‐income...
Saved in:
Main Authors: | R Perumal, V Naidoo, S Govender, T N Gengiah |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2023-12-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/1066 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context
by: Podjanee Jittamala, et al.
Published: (2025-02-01) -
Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01) -
Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01) -
Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
by: Jaehyeon Hwang, et al.
Published: (2025-01-01) -
p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low Cytotoxicity
by: Rui Ding, et al.
Published: (2025-01-01)